When APC are not infected by pathogens or when cancer antigens are not expressed in APC, the induction of cross-presentation using a vaccine platform is an attractive method to improve uptake and presentation of antigens to prime naive CD8+ T cells and mount an effective cellular immune response. Here, CD8A is linked to cancer.